134 related articles for article (PubMed ID: 32472749)
21. Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Schüttrumpf L; Marschner S; Scheu K; Hess J; Rietzler S; Walch A; Baumeister P; Kirchner T; Ganswindt U; Zitzelsberger H; Belka C; Maihoefer C
Radiat Oncol; 2020 Jan; 15(1):7. PubMed ID: 31906998
[TBL] [Abstract][Full Text] [Related]
22. Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy.
Adjei Boakye E; Buchanan P; Hinyard L; Stamatakis K; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Laryngoscope; 2019 Aug; 129(8):1828-1835. PubMed ID: 30582167
[TBL] [Abstract][Full Text] [Related]
23. Association of Symptoms and Clinical Findings With Anticipated Outcomes in Patients With Recurrent Head and Neck Cancer.
Pipkorn P; Licata J; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):738-745. PubMed ID: 30003215
[TBL] [Abstract][Full Text] [Related]
24. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
[TBL] [Abstract][Full Text] [Related]
25. A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma.
Teknos TN; Grecula J; Agrawal A; Old MO; Ozer E; Carrau R; Kang S; Rocco J; Blakaj D; Diavolitsis V; Kumar B; Kumar P; Pan Q; Palettas M; Wei L; Baiocchi R; Savvides P
Invest New Drugs; 2019 Aug; 37(4):702-710. PubMed ID: 30569244
[TBL] [Abstract][Full Text] [Related]
26. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma.
Sineshaw HM; Ellis MA; Yabroff KR; Han X; Jemal A; Day TA; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):247-255. PubMed ID: 31944232
[TBL] [Abstract][Full Text] [Related]
27. Adherence to pretreatment and intratreatment imaging of head and neck squamous cell carcinoma patients undergoing (chemo) radiotherapy in a research setting.
Martens RM; Koopman T; Noij DP; de Bree R; Vergeer MR; Zwezerijnen G; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Clin Imaging; 2021 Jan; 69():82-90. PubMed ID: 32693228
[TBL] [Abstract][Full Text] [Related]
28. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
[TBL] [Abstract][Full Text] [Related]
29. Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.
Sridharan V; Rahman RM; Huang RY; Chau NG; Lorch JH; Uppaluri R; Haddad RI; Hanna GJ; Schoenfeld JD
Oral Oncol; 2018 Oct; 85():29-34. PubMed ID: 30220316
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of advanced lung cancer inflammation index in head and neck squamous cell carcinoma.
Jank BJ; Kadletz L; Schnöll J; Selzer E; Perisanidis C; Heiduschka G
Eur Arch Otorhinolaryngol; 2019 May; 276(5):1487-1492. PubMed ID: 30877423
[TBL] [Abstract][Full Text] [Related]
31. Factors Associated With the Choice of Radiation Therapy Treatment Facility in Head and Neck Cancer.
Sullivan CB; Al-Qurayshi Z; Anderson CM; Seaman AT; Pagedar NA
Laryngoscope; 2021 May; 131(5):1019-1025. PubMed ID: 32846018
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
[TBL] [Abstract][Full Text] [Related]
33. Survival analysis of head and neck squamous cell carcinoma: influence of smoking and drinking.
Farshadpour F; Kranenborg H; Calkoen EV; Hordijk GJ; Koole R; Slootweg PJ; Terhaard CH
Head Neck; 2011 Jun; 33(6):817-23. PubMed ID: 20737489
[TBL] [Abstract][Full Text] [Related]
34. Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis.
Hamilton SN; Tran E; Berthelet E; Wu J; Olson R
Head Neck; 2018 Nov; 40(11):2432-2440. PubMed ID: 30295975
[TBL] [Abstract][Full Text] [Related]
35. Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer.
Mäkitie AA; Almangush A; Rodrigo JP; Ferlito A; Leivo I
Head Neck; 2019 Oct; 41(10):3712-3718. PubMed ID: 31328847
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation.
Alsidawi S; Price KA; Chintakuntlawar AV; Westin GF; Garcia JJ; Ma DJ; Okuno SH
Oral Oncol; 2017 Sep; 72():104-109. PubMed ID: 28797445
[TBL] [Abstract][Full Text] [Related]
37. Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01).
Lee YG; Kang EJ; Keam B; Choi JH; Kim JS; Park KU; Lee KE; Kwon JH; Lee KW; Kim MK; Ahn HK; Shin SH; Kim HR; Kim SB; Yun HJ
BMC Cancer; 2020 Aug; 20(1):813. PubMed ID: 32854649
[TBL] [Abstract][Full Text] [Related]
38. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.
Zhang XM; Song LJ; Shen J; Yue H; Han YQ; Yang CL; Liu SY; Deng JW; Jiang Y; Fu GH; Shen WW
Hum Pathol; 2018 Dec; 82():104-112. PubMed ID: 30036594
[TBL] [Abstract][Full Text] [Related]
40. ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.
Patel MR; Zhao N; Ang MK; Stadler ME; Fritchie K; Weissler MC; Zanation AM; Harris SL; Funkhouser WK; Olshan AF; Shores CG; Hayes DN
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):587-95. PubMed ID: 23846458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
